EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LncRNA HULC augments high glucose‐associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy

Ankita Sharma, Shibasish Chowdhury, Sudeshna Mukherjee, Rajdeep Chowdhury iD

Biology of the Cell · 2024

DOI: 10.1111/boc.202400034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of the Cell, 2024. Verfasst von Ankita Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India. Hauptthemen laut MEDLINE: Autophagy, Drug Resistance, Neoplasm, Pancreatic Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Engineering Research Board (SERB).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Information: One of the confounding factors in pancreatic cancer (PC) pathogenesis is hyperglycemia. The molecular mechanism by which high glucose (HG) influences PC severity is poorly understood. Our investigation delved into the impact of lncRNA highly upregulated in liver cancer (HULC) and its interaction with yes‐associated protein (YAP) in regulating the fate of pancreatic ductal adenocarcinoma cells (PDAC) under HG‐induced conditions. PDAC cells were cultured under normal or HG conditions. We thereafter measured the effect of HG on the viability of PDAC cells, their migration potential and drug resistance properties. The lncRNAs putatively dysregulated in PC and diabetes were shortlisted by bioinformatics analysis followed by wet lab validation of function.

Results

HG led to enhanced proliferation and drug refractoriness in PDAC cells. HULC was identified as one of the major deregulated lncRNAs following bioinformatics analysis. HULC was found to regulate the expression of the potent transcriptional regulator – YAP through selective histone modifications at the YAP promoter. siRNA‐mediated ablation of HULC resulted in a concurrent decrease in YAP transcriptional activity. Importantly, HULC and YAP were found to co‐operatively regulate the cellular homeostatic process autophagy, thus inculcating drug resistance and proliferative potential in PDAC cells. Moreover, inhibition of autophagy or YAP led to a decrease in HULC levels, suggesting the existence of an inter‐regulatory feedback loop.

Conclusions

We observed that HG triggers aggressive properties in PDAC cells. Mechanistically, up‐regulation of lncRNA HULC resulted in activation of YAP and differential regulation of autophagy coupled to increased proliferation of PDAC cells. Significance: Inhibition of HULC and YAP may represent a novel therapeutic strategy for PDAC. Furthermore, this study portrays the intricate molecular interplay between HULC, YAP and autophagy in PDAC pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyDrug Resistance, NeoplasmPancreatic NeoplasmsRNA, Long NoncodingTranscription FactorsYAP-Signaling ProteinsHumansAdaptor Proteins, Signal TransducingCarcinoma, Pancreatic DuctalCell Line, TumorCell MovementCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticGlucose

Stichwörter der Autor:innen

HULCYAPhyperglycemialncRNApancreatic cancer

Substanzen

Adaptor Proteins, Signal TransducingGlucoseHULC long non-coding RNA, humanRNA, Long NoncodingTranscription FactorsYAP-Signaling ProteinsYAP1 protein, human

Autor:innen und Institutionen

  • Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India.

ORCID-Profile: Rajdeep Chowdhury

Förderung

  • Science and Engineering Research Board (SERB)

Zitieren

APA

Sharma, A., Chowdhury, S., Mukherjee, S., & Chowdhury, R. (2024). LncRNA HULC augments high glucose‐associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy. Biology of the Cell. https://doi.org/10.1111/boc.202400034

Vancouver

Sharma A, Chowdhury S, Mukherjee S, Chowdhury R. LncRNA HULC augments high glucose‐associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy. Biology of the Cell. 2024. doi:10.1111/boc.202400034

BibTeX
@article{Sharma2024,
  author = {Sharma, Ankita and Chowdhury, Shibasish and Mukherjee, Sudeshna and Chowdhury, Rajdeep},
  title = {LncRNA HULC augments high glucose‐associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy},
  journal = {Biology of the Cell},
  year = {2024},
  doi = {10.1111/boc.202400034}
}
Kostenlos starten →